🇺🇸 FDA
Pipeline program

Exparel 266 MG Per 20 ML Injection

SJHC80

Approved small_molecule active

Quick answer

Exparel 266 MG Per 20 ML Injection for Post Operative Pain is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Post Operative Pain
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials